02 May 2003 : Case report
Topical treatment with BGP-15M, a poly(ADP-ribose) polymerase inhibitor protects from ultraviolet radiation-induced skin cancer in vivo
B. Farkas, M. Magyarlaki, B. Csete, S. BernathMed Sci Monit 2003; 9(1): 25-0 :: ID: 15075
Abstract
Experimental data suggest that enzymes and substances, which decrease DNA-damage or improve repair can be used as photoprotective agents. These observations have led to the development of new strategies to facilitate DNA-repair in human cells and thereby improve photoprotection [1–3]. UV-irradiation may have deleterious effects on the DNA of skin cells. Indeed, UV-irradiation is capable of inducing extensive DNA-damage that overactivates PARP causing increased energy demand, which in turn may result in collapse of energy metabolism and in cell death. This suggests that moderation of PARP activity following DNA-damage may protect skin cells from the harmful effects of acute and chronic UV-exposure.The effects of BGP-15M, a topically applied novel PARP-inhibitor on UV-induced acute and chronic photodamage were investigated in a hairless mouse model and in human skin. DNA injury was detected by measuring the formation of single-strand DNA breaks and counting sunburn cells. The ADP-ribosylation of PARP was assessed by Western blot analysis. Immunosuppression was investigated in epidermal cells by detecting TNFá and IL-10 expression. UV-induced photocarcinogenesis was determined by clinical, immunohistochemical, and biochemical methods. It has been observed that BGP-15M protects against the clinical and histopathological signs of long-term (26 week) UVA exposure in 8-methoxipsoralen sensitized skin, and decreases the UVB-induced accumulation of mutations and deletions in tumor suppressor genes. Topical treatment with BGP-15M prevents photocarcinogenesis induced by long-term, 32 week-UVB or 26 week-UVA exposure in hairless mice. The above observations carry the promise of a novel type biological skin protective agent against UV-induced photocarcinogenesis, which can revolutionize sun protection in the coming years. References: 1.Yarosh D et al: Lancet, 2001; 357: 926 2.Farkas B et al: Biochem Pharmacol, 2002; 63: 921 3.Farkas B et al: Pharmacology & Toxicology Series, Boca Raton, London, Washington, CRC Press 2002; pp: 257
Keywords: topical PARP-inhibitor, skin cancer, UVA, UVB, photoprotection
Editorial
01 April 2025 : Editorial
Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to HumansDOI: 10.12659/MSM.949109
Med Sci Monit 2025; 31:e949109
In Press
Clinical Research
Buccal Acupuncture Reduces the Dose of Sufentanil Needed in Laparoscopic Gynecological SurgeryMed Sci Monit In Press; DOI: 10.12659/MSM.947088
Review article
Global Guidelines and Trends in HPV Vaccination for Cervical Cancer PreventionMed Sci Monit In Press; DOI: 10.12659/MSM.947173
Clinical Research
Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelome...Med Sci Monit In Press; DOI: 10.12659/MSM.947873
Clinical Research
Impact of Depression, Fatigue, and Pain on Quality of Life in Slovak Multiple Sclerosis PatientsMed Sci Monit In Press; DOI: 10.12659/MSM.947630
Most Viewed Current Articles
17 Jan 2024 : Review article 7,932,897
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,919
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 29,882
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 23,844
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912